Skip to main content
. Author manuscript; available in PMC: 2017 Feb 28.
Published in final edited form as: Neuroscience. 2015 Jan 28;290:159–164. doi: 10.1016/j.neuroscience.2015.01.029

Fig 2.

Fig 2

Infusion of the glutamate antagonists CNQX (50 µM) and AP-5 (200 µM) into the VTA blocks 5-HT2 agonist (DOI)-induced mesocortical DA release. A combination of the glutamate antagonists was infused into the VTA at the time indicated by the bar. DOI was injected (2.5 mg/kg s.c.) at the time indicated by the arrow. *p < 0.05 relative to the VEH + VEH group and the CNQX/AP-5 + DOI group, n = 5–6/group.